journal
https://read.qxmd.com/read/38525776/-advances-in-respiratory-medicine-aims-and-scopes-update
#1
EDITORIAL
Krzysztof Kuziemski, Monika Franczuk, Sebastian Majewski, Tadeusz M Zielonka, Adam Barczyk
Advances in Respiratory Medicine , which has been published by MDPI since 2022, serves as a platform for hosting pneumological studies [...].
March 19, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38525775/outcomes-and-functional-deterioration-in-hospital-admissions-with-acute-hypoxemia
#2
JOURNAL ARTICLE
Susanne Simon, Jens Gottlieb, Ina Burchert, René Abu Isneineh, Thomas Fuehner
BACKGROUND: Many hospitalized patients decline in functional status after discharge, but functional decline in emergency admissions with hypoxemia is unknown. The primary aim of this study was to study functional outcomes as a clinical endpoint in a cohort of patients with acute hypoxemia. METHODS: A multicenter prospective observational study was conducted in patients with new-onset hypoxemia emergently admitted to two respiratory departments at a university hospital and an academic teaching hospital...
March 6, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38525774/association-between-the-static-and-dynamic-lung-function-and-ct-derived-thoracic-skeletal-muscle-measurements-a-retrospective-analysis-of-a-12-month-observational-follow-up-pilot-study
#3
JOURNAL ARTICLE
Mia Solholt Godthaab Brath, Sisse Dyrman Alsted, Marina Sahakyan, Esben Bolvig Mark, Jens Brøndum Frøkjær, Henrik Højgaard Rasmussen, Lasse Riis Østergaard, Rasmus Brath Christensen, Ulla Møller Weinreich
BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) with low skeletal muscle mass and severe airway obstruction have higher mortality risks. However, the relationship between dynamic/static lung function (LF) and thoracic skeletal muscle measurements (SMM) remains unclear. This study explored patient characteristics (weight, BMI, exacerbations, dynamic/static LF, sex differences in LF and SMM, and the link between LF and SMM changes. METHODS: A retrospective analysis of a 12-month prospective follow-up study patients with stable COPD undergoing standardized treatment, covering mild to severe stages, was conducted...
March 6, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38525773/advancing-care-in-severe-asthma-the-art-of-switching-biologics
#4
REVIEW
Silvano Dragonieri, Andrea Portacci, Vitaliano Nicola Quaranta, Giovanna Elisiana Carpagnano
Biologics targeting IgE, IL-5, IL-4/IL-13, and TSLP are crucial in severe asthma treatment. Research, including randomized controlled trials and real-world studies, has been conducted to assess their efficacy and identify patient characteristics that may predict positive responses. The effectiveness of switching biologics, especially given overlaps in treatment eligibility, and the clinical outcomes post-cessation are critical areas of investigation. This work reviews the effects of switching between these biologics and the indicators of treatment success or failure...
February 21, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38392036/the-growing-understanding-of-the-pituitary-implication-in-the-pathogenesis-of-long-covid-19-syndrome-a-narrative-review
#5
REVIEW
Ach Taieb, Ben Haj Slama Nassim, Gorchane Asma, Methnani Jabeur, Saad Ghada, Ben Abdelkrim Asma
Long COVID-19, also known as post-acute sequelae of SARS-CoV-2 infection, is a condition where individuals who have recovered from the acute phase of COVID-19 continue to experience a range of symptoms for weeks or even months afterward. While it was initially thought to primarily affect the respiratory system, it has become clear that Long COVID-19 can involve various organs and systems, including the endocrine system, which includes the pituitary gland. In the context of Long COVID-19, there is a growing understanding of the potential implications for the pituitary gland...
February 14, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38392035/administering-nitric-oxide-no-with-high-flow-nasal-cannulas-a-simple-method
#6
JOURNAL ARTICLE
Vladimir L Cousin, Raphael Joye, Angelo Polito
Inhaled nitric oxide (iNO) is a pulmonary vasodilator that plays an important clinical ICU role. The administration of iNO is usually performed through an endotracheal tube, but spontaneously breathing patients might also benefit from iNO administration. The use of the non-invasive administration of iNO through high-flow nasal cannula (HFNC) allows for NO delivery in spontaneously breathing patients who still need supplemental oxygen and positive airway pressure. A simple method to administer NO through HFNC is described here using standard commercially available NO administration and HFNC...
February 8, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38392037/correction-patsaki-et-al-benefits-from-incorporating-virtual-reality-in-pulmonary-rehabilitation-of-copd-patients-a-systematic-review-and-meta-analysis-adv-respir-med-2023-91-324-336
#7
Irini Patsaki, Vasiliki Avgeri, Theodora Rigoulia, Theodoros Zekis, George A Koumantakis, Eirini Grammatopoulou
Error in Figure 3 [...].
February 1, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38392034/constructing-a-nomogram-model-to-estimate-the-risk-of-ventilator-associated-pneumonia-for-elderly-patients-in-the-intensive-care-unit
#8
JOURNAL ARTICLE
Wensi Gan, Zhihui Chen, Zhen Tao, Wenyuan Li
BACKGROUND: Ventilator-associated pneumonia (VAP) causes heavy losses in terms of finances, hospitalization, and death for elderly patients in the intensive care unit (ICU); however, the risk is difficult to evaluate due to a lack of reliable assessment tools. We aimed to create and validate a nomogram to estimate VAP risk to provide early intervention for high-risk patients. METHODS: Between January 2016 and March 2021, 293 patients from a tertiary hospital in China were retrospectively reviewed as a training set...
January 19, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38247553/clinical-effectiveness-of-ritonavir-boosted-nirmatrelvir-a-literature-review
#9
REVIEW
Sydney Paltra, Tim O F Conrad
Nirmatrelvir/Ritonavir is an oral treatment for mild to moderate COVID-19 cases with a high risk for a severe course of the disease. For this paper, a comprehensive literature review was performed, leading to a summary of currently available data on Nirmatrelvir/Ritonavir's ability to reduce the risk of progressing to a severe disease state. Herein, the focus lies on publications that include comparisons between patients receiving Nirmatrelvir/Ritonavir and a control group. The findings can be summarized as follows: Data from the time when the Delta-variant was dominant show that Nirmatrelvir/Ritonavir reduced the risk of hospitalization or death by 88...
January 18, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38247552/breathing-pattern-response-after-6-weeks-of-inspiratory-muscle-training-during-exercise
#10
JOURNAL ARTICLE
Eduardo Salazar-Martínez
(1) Background: The breathing pattern is defined as the relationship between the tidal volume (VT) and breathing frequency (BF) for a given VE. The aim of this study was to evaluate whether inspiratory muscle training influenced the response of the breathing pattern during an incremental effort in amateur cyclists. (2) Methods: Eighteen amateur cyclists completed an incremental test to exhaustion, and a gas analysis on a cycle ergometer and spirometry were conducted. Cyclists were randomly assigned to two groups (IMTG = 9; CON = 9)...
January 17, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38247551/pulmonary-embolism-pe-to-chronic-thromboembolic-pulmonary-disease-ctepd-findings-from-a-survey-of-uk-physicians
#11
JOURNAL ARTICLE
Joanna Pepke-Zaba, Luke Howard, David G Kiely, Shruti Sweeney, Martin Johnson
Chronic thromboembolic pulmonary disease (CTEPD) is a complication of pulmonary embolism (PE). We conducted an online survey of UK PE-treating physicians to understand practices in the follow-up of PE and awareness of CTEPD. The physicians surveyed ( N = 175) included 50 each from cardiology, respiratory and internal medicine, plus 25 haematologists. Most (89%) participants had local guidelines for PE management, and 65% reported a PE follow-up clinic, of which 69% were joint clinics. Almost half (47%) had a protocol for the investigation of CTEPD...
January 9, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38247550/predictive-value-of-fractional-exhaled-nitric-oxide-feno-in-the-diagnosis-of-asthma-for-epidemiological-purposes-an-8-year-follow-up-study
#12
JOURNAL ARTICLE
Kamil Barański
UNLABELLED: At the population level, respiratory symptoms in children can be estimated cross-sectionally. However, such methods require additional objective support parameters, such as the measurement of fractional exhaled nitric oxide (FeNO). The aim of the present study was to analyze if the FeNO value measured at baseline can have a predictive value for asthma-like symptoms after 8 years of measurement. METHODS: The follow-up included 128 (out of 447) children, 70 girls and 58 boys...
January 4, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38247549/expression-of-inflammatory-genes-in-murine-lungs-in-a-model-of-experimental-pulmonary-hypertension-effects-of-an-antibody-based-targeted-delivery-of-interleukin-9
#13
JOURNAL ARTICLE
Judith Heiss, Katja Grün, Isabell Singerer, Laura Tempel, Mattia Matasci, Christian Jung, Alexander Pfeil, P Christian Schulze, Dario Neri, Marcus Franz
BACKGROUND: Pathogenesis of pulmonary hypertension (PH) is a multifactorial process driven by inflammation and pulmonary vascular remodeling. To target these two aspects of PH, we recently tested a novel treatment: Interleukin-9 (IL9) fused to F8, an antibody that binds to the extra-domain A of fibronectin (EDA+ Fn). As EDA+ Fn is not found in healthy adult tissue but is expressed during PH, IL9 is delivered specifically to the tissue affected by PH. We found that F8IL9 reduced pulmonary vascular remodeling and attenuated PH compared with sham-treated mice...
January 3, 2024: Advances in Respiratory Medicine
https://read.qxmd.com/read/38247548/reply-to-salimi-m-comment-on-patsaki-et-al-benefits-from-incorporating-virtual-reality-in-pulmonary-rehabilitation-of-copd-patients-a-systematic-review-and-meta-analysis-adv-respir-med-2023-91-324-336
#14
JOURNAL ARTICLE
Irini Patsaki, Vasiliki Avgeri, Theodora Rigoulia, Theodoros Zekis, George A Koumantakis, Eirini Grammatopoulou
We are writing in response to the comment [...].
December 22, 2023: Advances in Respiratory Medicine
https://read.qxmd.com/read/38392033/the-added-value-of-bronchoalveolar-lavage-for-pulmonary-tuberculosis-diagnosis-in-high-risk-hospitalized-patients-with-negative-sputum-samples
#15
JOURNAL ARTICLE
Ophir Freund, Yitzhac Hadad, Tomer Lagziel, Inbal Friedman Regev, Eyal Kleinhendler, Avraham Unterman, Amir Bar-Shai, Tal Moshe Perluk
Hospitalized patients with a high suspicion of pulmonary tuberculosis (HS-PTB) are isolated until a definite diagnosis can be determined. If doubt remains after negative sputum samples, bronchoscopy with bronchoalveolar lavage (BAL) is often sought. Still, evidence of the added value of BAL in this patient population is scarce. To address this issue, we included consecutive HS-PTB patients with negative sputum samples who underwent BAL between 2017 and 2018. Chest X-rays (CXR) and CT scans were evaluated by a chest radiologist blind to the final diagnosis...
December 21, 2023: Advances in Respiratory Medicine
https://read.qxmd.com/read/38392032/comment-on-patsaki-et-al-benefits-from-incorporating-virtual-reality-in-pulmonary-rehabilitation-of-copd-patients-a-systematic-review-and-meta-analysis-adv-respir-med-2023-91-324-336
#16
JOURNAL ARTICLE
Mostafa Salimi
I am writing this comment regarding the review article by Patsaki et al. titled "Benefits from Incorporating Virtual Reality in Pulmonary Rehabilitation of COPD Patients: A Systematic Review and Meta-Analysis" [...].
December 20, 2023: Advances in Respiratory Medicine
https://read.qxmd.com/read/38392031/testing-alpha-1-antitrypsin-deficiency-in-black-populations
#17
REVIEW
Pascale Lafortune, Kanza Zahid, Magdalena Ploszaj, Emilio Awadalla, Tomás P Carroll, Patrick Geraghty
Alpha-1 antitrypsin (AAT) deficiency (AATD) is an under-recognized hereditary disorder and a significant cause of chronic obstructive pulmonary disease (COPD), a disease that contributes to global mortality. AAT is encoded by the SERPINA1 gene, and severe mutation variants of this gene increase the risk of developing COPD. AATD is more frequently screened for in non-Hispanic White populations. However, AATD is also observed in other ethnic groups and very few studies have documented the mutation frequency in these other ethnic populations...
December 19, 2023: Advances in Respiratory Medicine
https://read.qxmd.com/read/38131877/the-baveno-classification-as-a-predictor-of-cpap-titration-pressure-in-obstructive-sleep-apnea-syndrome
#18
JOURNAL ARTICLE
Ahmed Ehab, Axel T Kempa, Harald Englert, Shaza Almasri Bittar, Aida M Yousef, Heba Wagih Abdelwahab
INTRODUCTION: Obstructive sleep apnea syndrome (OSAS) is a clinical condition characterised by repeated periods of partial or full obstruction of airflow throughout sleep, with impairment of the quality of life and increased mortality with socioeconomic impacts. CPAP therapy is a simple and effective treatment option for OSAS patients. To overcome the clinical and prognostic limitations of AHI-as a sole index of OSAS-the Baveno classification was recently set out and introduced into clinical practice...
December 15, 2023: Advances in Respiratory Medicine
https://read.qxmd.com/read/38131876/risk-factors-contributing-to-reinfection-by-sars-cov-2-a-systematic-review
#19
JOURNAL ARTICLE
Walter Gómez-Gonzales, Luis A Chihuantito-Abal, Carlos Gamarra-Bustillos, Julia Morón-Valenzuela, Jenny Zavaleta-Oliver, Maria Gomez-Livias, Lidia Vargas-Pancorbo, María E Auqui-Canchari, Henry Mejía-Zambrano
This article aims to systematize the evidence regarding risk factors associated with COVID-19 reinfection. We conducted a systematic review of all the scientific publications available until August 2022. To ensure the inclusion of the most recent and relevant information, we searched the PubMed and Scopus databases. Thirty studies were reviewed, with a significant proportion being analytical observational case-control and cohort studies. Upon qualitative analysis of the available evidence, it appears that the probability of reinfection is higher for individuals who are not fully immunized when exposed to a new variant, females, those with pre-existing chronic diseases, individuals aged over 60, and those who have previously experienced severe symptoms of the disease or are immunocompromised...
December 6, 2023: Advances in Respiratory Medicine
https://read.qxmd.com/read/38131875/correlation-between-cardiovascular-autonomic-and-pulmonary-ventilation-functions-in-myasthenia-gravis-patients
#20
JOURNAL ARTICLE
Monika Zawadka-Kunikowska, Łukasz Rzepiński, Mirosława Cieślicka, Joanna Fanslau, Jacek J Klawe, Małgorzata Tafil-Klawe
This study aimed to investigate the relationship between pulmonary function and cardiac autonomic function parameters in clinically stable myasthenia gravis (MG) patients. A total of 22 MG patients and 22 healthy controls (HCs) were evaluated. Pulmonary function test parameters, heart rate variability (HRV), baroreflex sensitivity (BRS), and cardiovascular autonomic function test parameters (the Valsalva ratio, expiration/inspiration (E/I) ratio) were assessed. Compared with the HCs, the patients demonstrated a similar diffusion capacity for carbon monoxide (DLCO ); a lower forced vital capacity (FVC%pred ); a lower forced expiratory volume in 1 s (FEV1%pred ); lower BRS and HRV, including high-frequency and total power spectral density; and a higher percentage of abnormal cardiovagal function test results ( p < 0...
December 1, 2023: Advances in Respiratory Medicine
journal
journal
53971
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.